Trade AMPLIFON - AMPI CFD

Trading Conditions

• Type: CFD
• Spread: 0.06
• Long position overnight funding adjustment: -0.01660%
• Short position overnight funding adjustment: -0.00562%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: EUR
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: Italy
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 10.49
• Open: 9.78
• 1-Year Change: -51%
• Day's Range: 8.88 - 9.92

What is AMPLIFON (AMPI)?

Amplifon is a global company specializing in hearing care solutions and services. It operates a network of retail locations and clinics offering hearing assessments, hearing aids, and related accessories. Amplifon provides personalized hearing care through audiological services, fitting, and aftercare support. The company collaborates with manufacturers to offer a range of hearing aid technologies catering to different levels of hearing loss. Amplifon's business model integrates clinical expertise with retail operations to address hearing health needs. It serves a broad customer base across multiple countries, emphasizing accessibility and quality in hearing care. The company contributes to the healthcare sector by enhancing auditory wellness and communication.

AMPLIFON Stock Price Today: Live Overview

The price today is shaped by ongoing intraday movements with AMPLIFON at €9.05. The observed price range today falls between €8.82 and €10.29, with a daily change percentage of -13.4542%.

FAQ: AMPLIFON (AMPI)

What is the current price of AMPI stock?

The current price is €9.05.

Does AMPI pay dividends?

AMPLIFON pays dividends via cash distributions (if applicable).

Does AMPI have a formal corporate presence or regional headquarters in the UAE?

The company has a registered presence in the UAE but no specific office in regional free zones.

What is AMPI best known for?

AMPLIFON is most famous for its hearing aid products and audiology services.

What assets are typically shown together with AMPI?

Commonly shown alongside AMPI: Delcath Systems, Inc., Castle Biosciences Inc., iShares iBonds Dec 2026 Term Treasury ETF